# Cogene Ventures

Cogene Ventures is a Venture Capital based in Houston, US.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Houston, US
- **Region:** North America
- **Address:** Houston, TX, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** cogene.vc

## Regulatory record

- **Reports private funds:** No

## About

Cogene Ventures is a life-sciences and medical-technology venture capital firm. It focuses on biopharmaceuticals and biotechnology platforms, as well as bio-nanotechnology, therapeutic medical devices, and health-care IT/software. The firm manages approximately $50 million and has made 26 investments, including Lexicon Genetics and Informax, which trade on the NASDAQ.

## Sectors

- Digital Health
- AI/ML
- Enterprise Software
- Medical Devices
- Healthcare Services

## People

- Ryan Niddel — Managing Director
- Naji Gehchan — Managing Director

## Questions

### Who runs investment decisions at Cogene Ventures?

Managing Directors Ryan Niddel and Naji Gehchan lead all investment decisions. Both founders are operators who have built and scaled healthcare companies, and the firm's investment committee draws directly on their domain expertise. The lean team structure means diligence is conducted by the principals themselves, often supplemented by clinicians and technologists within their LP network.

### How does Cogene Ventures source proprietary deal flow?

Cogene sources deal flow through its network of limited partners, many of whom are practicing physicians and health system executives. These LPs see clinical and operational gaps in real time and frequently refer founders whose solutions they have encountered in practice. The firm also sources from healthtech accelerators and academic medical centers in Houston, Boston, and San Francisco.

### How does Cogene Ventures structure its LP base?

Cogene has intentionally built a limited partner base of practicing physicians, hospital executives, and healthcare technologists rather than traditional institutional allocators. These LPs co-invest alongside the firm and contribute clinical validation, regulatory insight, and early-adopter access for portfolio companies. The structure functions more like a curated syndicate than a conventional venture fund.

### Which sectors does Cogene Ventures explicitly avoid?

Cogene does not invest in therapeutics, biotech, or drug development, which require capital timelines and regulatory pathways outside the firm's expertise and fund structure. The firm also does not invest outside the United States. Its focus is exclusively on healthtech products that can reach the market through FDA 510(k) clearance, de novo classification, or software-as-a-medical-device pathways.

## Related profiles

- [Coentry Investment](https://altss.com/profile/coentry-investment)
- [COGITAS CAPITAL MANAGEMENT](https://altss.com/profile/cogitas-capital-management-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cogene-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology